Viaderma Stock Analysis

Viaderma Pink Sheet Analysis Notes

The company has Price to Book (P/B) ratio of 0.0. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Viaderma had not issued any dividends in recent years. The entity had 1:50 split on the 6th of May 2014. ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California. Viaderma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.The quote for Viaderma is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 310 496 5744 or visit https://viadermalicensing.com.

Viaderma Investment Alerts

Viaderma Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 82.27 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Viaderma's market, we take the total number of its shares issued and multiply it by Viaderma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 19th of February, Viaderma has the Semi Deviation of 13.04, coefficient of variation of 532.17, and Risk Adjusted Performance of 0.1585. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viaderma, as well as the relationship between them. Please validate Viaderma variance, as well as the relationship between the value at risk and skewness to decide if Viaderma is priced more or less accurately, providing market reflects its prevalent price of 4.0E-4 per share. As Viaderma appears to be a penny stock we also recommend to double-check its total risk alpha numbers.

Viaderma Price Movement Analysis

Viaderma Outstanding Bonds

Viaderma Predictive Daily Indicators

Viaderma Forecast Models

Viaderma's time-series forecasting models are one of many Viaderma's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Viaderma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Viaderma Debt to Cash Allocation

The company has a current ratio of 0.28, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Viaderma until it has trouble settling it off, either with new capital or with free cash flow. So, Viaderma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Viaderma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Viaderma to invest in growth at high rates of return. When we think about Viaderma's use of debt, we should always consider it together with cash and equity.

Viaderma Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Viaderma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Viaderma, which in turn will lower the firm's financial flexibility.

Viaderma Corporate Bonds Issued

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Viaderma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Viaderma shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Viaderma. By using and applying Viaderma Pink Sheet analysis, traders can create a robust methodology for identifying Viaderma entry and exit points for their positions.

Viaderma financial ratios help investors to determine whether Viaderma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viaderma with respect to the benefits of owning Viaderma security.